A postdoctoral position is available at UCLA to study the molecular mechanisms of novel therapeutic targets. We seek a highly motivated individual with a Ph.D. in biochemistry, cell biology or related fields. Prior experience with mass spectrometry or mouse models is preferred, but not required.
We are interested in the discovery and mechanistic study of cell-surface receptors for orphan ligands of biological and medical interest. Receptors are among the most successful therapeutic targets in treating human diseases. Our research is not driven by a particular technique, but employs a range of techniques to answer important questions (e.g., mass spectrometry for discovery-driven projects, high-throughput screening for drug discovery, and animal models for in vivo validation). For example, our research team has developed innovative techniques to identify small molecule modulators of the new type of transmembrane receptors we discovered. A recent example is a new screening technique that can identify chemical compounds that mimic the actions of a protein that has broad therapeutic value in treating major blinding diseases and several types of cancer.
Please send a CV and contact information for three references by e-mail to:
Hui Sun, Ph.D.
Department of Physiology
Jules Stein Eye Institute
Howard Hughes Medical Institute
David Geffen School of Medicine
University of California
Los Angeles, CA 90095
Email: hsun@mednet.ucla.edu
We are interested in the discovery and mechanistic study of cell-surface receptors for orphan ligands of biological and medical interest. Receptors are among the most successful therapeutic targets in treating human diseases. Our research is not driven by a particular technique, but employs a range of techniques to answer important questions (e.g., mass spectrometry for discovery-driven projects, high-throughput screening for drug discovery, and animal models for in vivo validation). For example, our research team has developed innovative techniques to identify small molecule modulators of the new type of transmembrane receptors we discovered. A recent example is a new screening technique that can identify chemical compounds that mimic the actions of a protein that has broad therapeutic value in treating major blinding diseases and several types of cancer.
Please send a CV and contact information for three references by e-mail to:
Hui Sun, Ph.D.
Department of Physiology
Jules Stein Eye Institute
Howard Hughes Medical Institute
David Geffen School of Medicine
University of California
Los Angeles, CA 90095
Email: hsun@mednet.ucla.edu
為防止簡(jiǎn)歷投遞丟失請(qǐng)抄送一份至：boshijob@126.com（郵件標(biāo)題格式：應(yīng)聘職位名稱+姓名+學(xué)歷+專業(yè)+中國(guó)博士人才網(wǎng)）
中國(guó)-博士人才網(wǎng)發(fā)布
聲明提示：凡本網(wǎng)注明“來(lái)源：XXX”的文/圖等稿件，本網(wǎng)轉(zhuǎn)載出于傳遞更多信息及方便產(chǎn)業(yè)探討之目的，并不意味著本站贊同其觀點(diǎn)或證實(shí)其內(nèi)容的真實(shí)性，文章內(nèi)容僅供參考。
